Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Adventrx Pharma takes over SynthRx
Following the acquisition, SynthRx’s lead product candidate, poloxamer 188, a novel, proprietary, rheologic and antithrombotic compound, will be developed by Adventrx as ANX-188. Adventrx CEO Brian Culley said
Following the acquisition, SynthRx’s lead product candidate, poloxamer 188, a novel, proprietary, rheologic and antithrombotic compound, will be developed by Adventrx as ANX-188. Adventrx CEO Brian Culley said
Merz Pharma claims Scar Gel and Stretch Marks Therapy are formulated with, a proprietary botanical extract derived from onions, Cepalin. Mederma Scar Gel is an invisible, greaseless, topical
Jones, the former COO at Astellas Pharma Europe, will succeed Masao Yoshida, who has been appointed as president and CEO of Astellas Pharma US, the US subsidiary of
DHL has decided to take over Bristol-Myers Squibb distribution centers in Mount Vernon, Indiana, and will acquire the operations in the second quarter of this year. Following the
AP301 activates alveolar liquid clearance (ALC) and prevents both endothelial and epithelial lung tissue from hyper-permeability as a result of microbial and viral lung infections. In the trial,
The partnership combines Sun Pharma’s expertise in product development using Sun Pharma Advanced Research Company’s (SPARC) proprietary platform technologies and manufacturing network with Merck’s clinical development and registration
The Phase 1 study will assess the safety and pharmacokinetic profiles of two different formulations of Fanapt in patients with schizophrenia. Under an agreement signed in 2009 with
Sativex is a cannabinoid medicine for the treatment of spasticity due to multiple sclerosis which is also in development in cancer pain and neuropathic pain of various origins.
Under the agreement, Heptares is expected to work on its proprietary StaR (stabilized receptor) technology to engineer its thermally stabilized forms of the GPCR as the basis for
The trial was designed to investigate the safety of three different doses of NP2 Enkephalin and also to investigate efficacy measurements of pain relief in subjects suffering from